FOLD icon

Amicus Therapeutics

227 hedge funds and large institutions have $4.71B invested in Amicus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 97 increasing their positions, 64 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

10% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 29

9.28% more ownership

Funds ownership: 104.01%113.29% (+9.3%)

0% more funds holding

Funds holding: 227227 (0)

Holders
227
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$51.8M
Puts
$11.3M
Net Calls
Net Calls Change

Top Buyers

1 +$226M
2 +$109M
3 +$79.9M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$68.7M
5
Blackstone Inc
Blackstone Inc
New York
+$35M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$404M
2
$398M
3
$389M
4
$378M
5
$326M
6
$253M
7
$216M
8
$210M
9
$187M
10
$165M
11
$163M
12
$147M
13
$102M
14
$99.3M
15
$84.5M
16
$82M
17
$71.8M
18
$65M
19
$40.4M
20
$38.4M
21
$35.9M
22
$35.5M
23
$35M
24
$34.3M
25
$32.2M